This feature article of The Economic Times (India) examines how MNCs use China as a leverage and their motivations for outsourcing through a recent dispute between Novartis and the Indian government over patentability of Novartis’ anti-cancer drug Glivec.


-----------------------------------------------------------------------------------------

This is not an article published by Pharma China, and please visit the following website link for the full text of the article.  The availability of the article is under the control of its publisher. 

http://economictimes.indiatimes.com/News/News_By_Industry/Healthcare__Biotech/
Pharmaceuticals/Pharma_MNCs_bullying_govt_with_China_sword/articleshow/2279285.cms

Note: By clicking on the above link, you will leave Pharma China Online. If you wish to return to this website, please click on "Back" button or log onto Pharma China Online again.